# Marc Riviere

> Marc Riviere is a startup investor at TVM Capital (Montréal). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [TVM Capital](https://shizune.co/investors/profile/tvm-capital)
- Location: Montréal, Canada
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/marcriviere119727a

Marc Riviere is a startup investor at TVM Capital in Montréal. Marc Rivière joined the Montreal-based TVM Capital Life Science team in 2013 after twenty years of international drug development preceded by ten years of medical and public health practice in Europe and the Middle East.An experienced executive with a track record in successfully building and managing clinical programs, Marc’s expertiseencompasses all aspects of drug development in different clinical indications from pre-clinical development to post marketing surveillance. At TVM Capital Life Science, he focuses on evaluation of deal opportunities and investment management for therapeutics. He also works closely with the firm’s strategic partner Eli Lilly & Co. and its drug development division Chorus. He also serves on the board of publicly listed (Euronext) Cerenis Therapeutics, Toulouse, France, Ann Arbor, USA. Prior to joining TVM Capital Life Science, Marc was Vice-President, Axcan Pharma Inc., in charge of Clinical Development, Medical Affairs and Pharmacovigilance and a member of the Axcan Licensing Committee. He also served as Senior Vice President, Clinical Development at Caprion Pharmaceuticals, Chief Medical Officer for Bioniche Life Sciences Inc., Managing Director of Xenon Genetics Inc., Vice President of Clinical Affairs, Aeterna Labs and Executive Vice President and Regional Director, Quintiles Inc. He was also member of the Guideline Review Committee of the Canadian Co-ordination Office of Health Technology Assessment. Marc received his Tropical Disease Medicine Certification from Université Bordeaux II, France and Medicine Doctorate from Université Paul Sabatier, Toulouse, France, and has over fifty publications and scientific communications to his credit.

## About TVM Capital

VC Fund · Munich, Germany

TVM Capital is a global venture and growth capital firm that aims to finance select biopharmaceutical and medical device companies. TVM Capital was founded in 1983 and is based Munich, Bavaria.

5 contacts available at TVM Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Hubert Birner | General Partner | https://shizune.co/investors/profile/hubert-birner |
| Luc Marengere | Managing Partner | https://shizune.co/investors/profile/luc-marengere |
| Christoph Schröder | General Partner | https://shizune.co/investors/profile/christoph-schrder |
| Friedrich Bornikoel | Managing Director | https://shizune.co/investors/profile/friedrich-bornikoel |
| Marc Riviere | General Partner | https://shizune.co/investors/profile/marc-rivi%C3%A8re |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co